Aptivus®

tipranavir

About Aptivus®

Indicated for combination antiretroviral treatment of HIV-1-infected patients, co-administered with 200 mg of ritonavir, who are treatment-experienced and infected with HIV-1 strains resistant to more than one protease inhibitor.

 

Professional Area

You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.

Product Key Facts

Indications

HIV/AIDS

Brand Names

Aptivus®

Active ingredients

tipranavir